The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is metronomic cyclophosphamide (mCTX) a therapeutic option for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the era of new agents (NAs)? A retrospective multicenter Italian study.
 
Orazio Caffo
Honoraria - Astellas Pharma; Janssen Oncology; Sanofi
 
Ugo De Giorgi
No Relationships to Disclose
 
Francesco Ferraú
No Relationships to Disclose
 
Maddalena Donini
No Relationships to Disclose
 
Gaetano Facchini
No Relationships to Disclose
 
Marco Maruzzo
No Relationships to Disclose
 
Marcello Tucci
No Relationships to Disclose
 
Vincenza Conteduca
No Relationships to Disclose
 
Francesca Maines
No Relationships to Disclose
 
Lorena Rossi
No Relationships to Disclose
 
Antonello Veccia
No Relationships to Disclose
 
Enzo Galligioni
No Relationships to Disclose